Two vaccines are currently available for the prevention of invasive pneumococcal disease in adults, namely the pneumococcal polysaccharide vaccine (PPV) and the pneumococcal conjugate vaccine (PCV).
Respiratory physicians say high-risk employees should get vaccinated against preventable infectious diseases, like pneumococcal pneumonia (12), to ensure a healthy workforce. (15)
Workers with comorbidities (1) and who are exposed to dust (2), chemicals, and toxic gases (3,4) are at risk of contracting occupational lung disease. (5)
People aged 65 years and older, as well as young adults with comorbidities, are at an increased risk of developing pneumonia (1,2) and may benefit from the pneumococcal vaccine. (3)